![]() | Only 14 pages are availabe for public view |
Abstract All people with diabetes mellitus are at risk of developing ocular complication those with type I diabetes (Juvenile onset) and those with type II diabetes (adult onset). The longer a person has diabetes, the higher the risk of developing some ocular problems. Diabetic retinopathy is one of the main causes of decreased eyesight and blindness in patients with diabetes mellitus. The current study aimed to: Investigate the association between plasma levels of PAI-1 enzyme, with diabetic retinopathy among Egyptian patients. Subjects and methods: from February 2011 to March 2012 Patients included in this study were recruited from those T2DM out-patients clinic attending to Fayoum University Teaching Hospital. The study was conducted on 70 subjects (40 females and 30 males). Group (1): 20 control normal healthy individuals. Group (2): 20 patients with type 2 diabetes who showed no signs of DR (diabetic without retinopathy group). Group (3): 30 patients with diabetic retinopathy (DR group). The diagnosis of diabetic retinopathy or its absence was confirmed by fundus examination and fluoresceine angiography (FA) in all patients. All patients and control groups were subjected to the following: • Full history taking (age of onset of diabetes, duration, medication and complication) and clinical examination for patients. • Measurement of body weight in kilograms • Measurement of height in meters • Calculation of body mass index (BM I) from the equation Weight (kg)/ height (m) 2 . Laboratory investigations included: PAI-1 activity by ELISA. Glycemic state by HbA1c. Cholesterol, triglycerides, HDL-cholesterol and calculated LDLcholesterol. RESULTS Regarding HbA1c, there was a very highly statistically significance difference (p <0.001) on comparing the three group with higher mean values in DR group (9.0 ± 0.3) than both DWR group (7.5 ± 0.8) and control group (4.9 ± 0.2). Regarding PAI-1 there was a statistical significance (p<0.05) on diabetic patients with retinopathy than without retinopathy. No statistical significance was found between the three groups as regards the LDL-cholesterol (p>0.05). No statistical significance was found between the three groups as regards the HDL-cholesterol (p>0.05). As regards total cholesterol, the mean value was higher in the DR group than other groups. There was a significant difference with P value <0.05 in both DR and DWR group figure Triglycerides, the mean value was higher in the DR group than control group with p value >0.05, however significant difference was found when control group compared to diabetic patients without retinopathy group with p value < 0.05, also when control compared and diabetic with retinopathy with p value < 0.001. There was correlation between PAI-1 and Triglycerides and between PAI-1 and Cholesterol. |